NetScientific (NSCI) is a holding company that invests, develops, commercialises and realises shareholder value in life sciences/healthcare, sustainability and technology companies.
Portfolio company PDS Biotechnology Corporation (Nasdaq: PDSB), in which NSCI holds a 4.72% stake, announced on 11 October, expanded interim data from a National Cancer Institute-led Phase II clinical study evaluating PDSB's lead candidate PDS0101 in combination with two Merck owned immune modulating drugs. The c ....
12 Oct 2022
WH Ireland: NetScientific (NSCI) - PDS Biotech – expanded interim data in PDS0101 triple combination
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
WH Ireland: NetScientific (NSCI) - PDS Biotech – expanded interim data in PDS0101 triple combination
NetScientific plc (NSCI:LON) | 63.0 0 0.0% | Mkt Cap: 15.1m
- Published:
12 Oct 2022 -
Author:
Matthew Davis | Emma Ulker -
Pages:
4
NetScientific (NSCI) is a holding company that invests, develops, commercialises and realises shareholder value in life sciences/healthcare, sustainability and technology companies.
Portfolio company PDS Biotechnology Corporation (Nasdaq: PDSB), in which NSCI holds a 4.72% stake, announced on 11 October, expanded interim data from a National Cancer Institute-led Phase II clinical study evaluating PDSB's lead candidate PDS0101 in combination with two Merck owned immune modulating drugs. The c ....